This modified lysine analog includes multiple protective groups and a cyclohexenone-derived substituent that affects steric bulk and electron distribution. The extended side chain allows exploration of metal coordination, conjugation chemistry, and conformational restriction. Researchers employ it in peptidomimetic scaffolding. Its dual protection facilitates selective transformations.
CAT No: R2146
CAS No:1428229-84-8
Synonyms/Alias:1428229-84-8;N2-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N6-(1-(2-hydroxy-4,4-dimethyl-6-oxocyclohex-1-en-1-yl)ethylidene)-N2-methyl-L-lysine;Fmoc-MeLys(Dde);AKOS030212444;(2S)-2-[9H-Fluoren-9-ylmethoxycarbonyl(methyl)amino]-6-[1-(2-hydroxy-4,4-dimethyl-6-oxocyclohexen-1-yl)ethylideneamino]hexanoic acid;
1. TMEM16F and dynamins control expansive plasma membrane reservoirs
2. High fat diet and GLP-1 drugs induce pancreatic injury in mice
5. Myotropic activity of allatostatins in tenebrionid beetles
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.